Mom's Bold Move: Back on Weight Loss Meds After Birth

Claudia Oshry has publicly shared her decision to resume taking weight loss medications, including Zepbound, following the birth of her son in May 2025. This announcement comes after a period where she had been off Ozempic, a drug she had been using since 2022. Oshry expressed immense pride in her weight loss journey, reflecting on past struggles with willpower and obesity, and now feels empowered by her choices.

Her return to medication marks a new phase in her personal health journey. Oshry detailed her initial fears of discontinuing Ozempic but found she was able to maintain her weight loss. She emphasized that her primary motivation for restarting medication was not a change in self-perception regarding her appearance, but rather a remarkable increase in her energy levels, which she described as life-altering.

Oshry, who welcomed her son Reuben with husband Ben Soffer on May 21, 2025, has been candid about the impact weight can have on various aspects of life, including relationships and career. Her experience underscores a commitment to well-being and the positive changes these medications have brought to her overall vitality and daily functioning.